Search liu.se

Our research team focuses on understanding the origins of blinding diseases of the cornea, evaluating new pharmacologic, surgical, and regenerative therapies to treat corneal disease.

Neil Lagali and Mehrdad Rafat earn global acclaim, winning ARVO Foundation's 2023 Point of View Award. Recognized by the world's largest eye research organization, their work in regenerative ophthalmology offers new hope for vision restoration.

Researchers at Linköping University are taking part in the largest European investment to date into diseases of the cornea. The aim is to restore vision in people with severe and rare eye diseases.

Some people who have recovered from COVID-19 have experienced long-term problems with their eyes. But why? And can this phenomenon be measured using biological markers? These are questions that researchers will try to answer in a new project.

Neil Lagali coordinates a research project that has received SEK 12.5 million from the European Joint Programme on Rare Diseases. The researchers will evaluate experimental treatments for a rare eye disease that affects sight directly from birth.

Professor Neil Lagali, eye researcher at BKV, is one of four eye researchers to share a research grant of 2 million Swedish crowns. – It is an honor for me to be chosen to share in this generous donation, says Neil.